Doc Gumshoe closes out 2022 with updates on Alzheimer's Disease, Flu Vaccines and more...
18 Comments Read MoreRelevant Updates – December 2022
An End of Life Narrative – December 2022
Short Bits for November
Doc Gumshoe with some updates on COVID-19, the polypill, diabetes, opioids and pain management, and more...
14 Comments Read MoreAnother Look at Heart Disease
Eifrig’s “Shock to Retirement” Pitch — Who are the winners of his “Health Care Singularity?”
Eifrig's new Prosperity Investor pitches Seven "Forever" stocks and three "1,000% Winner" speculations -- and the Thinkolator has definite answers for six of those ten below, plus a few guesses at the others...
27 Comments Read MoreOdd & Ends – October 2022
Stansberry Venture’s “Major Announcement” — What are the Three Companies facing a Wave of Money?
New ads pitch a special report called "Three Ways to Make Triple-Digit Gains on Flash-Radioimmunotherapy," and we've got the Thinkolator results ... plus, a note about the also-teased "Incredible Weight-Loss Drug"
22 Comments Read MoreParkinson’s Disease Today
Following Up on Your Suggestions – September 2022
Updates on Alzheimer's Disease, Anti-Inflammatories, Prostate Cancer, Vitamin D and more...
20 Comments Read MoreFrank Curzio teases “A $150 million market cap company with a real chance to make billions in annual revenue”
What's in Curzio's newest report, "The New Pill Set To Dominate The World’s Biggest Drug Market (And Make You Rich)"?
8 Comments Read MoreEarly Friday File: A New Model Candidate for the Lock Box
Catching Up on COVID and Keeping Up to Date on Monkeypox
Quickie: New Prosperity Investor stock teased by Eifrig
New teased stock -- "almost every medical student has used one of their products today..."
2 Comments Read MoreInflammation – What It Does for Us & What It Does to Us
What’s the Stock Behind Chris Wood’s “Magical” Anti-aging pill?
Friday File: Mampilly, Stansberry, Berkshire, Copper, and much more…
A hodgepodge of stories and updates... plus the start of earnings season for the Real Money Portfolio, and one "buy the dip" purchase
17 Comments Read MoreAlzheimer’s Drug Development — July Responses to Questions & Requests
Midsummer 2022 Morsels
Prosperity Investor
Alzheimer’s Disease June 2022 – Possible Signs of Progress